Results 31 to 40 of about 20,699 (254)

Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study

open access: yesJournal of Neural Transmission, 2022
AbstractAdverse drug reactions (ADRs) constitute a frequent cause of hospitalization in older people. The risk of ADRs is increased by the prescription of potentially inappropriate medications for older people (PIMs). The PRISCUS list and the FORTA classification represent established tools to detect PIMs.
Martin Schulze Westhoff   +11 more
openaire   +2 more sources

Assessing potentially inappropriate medication use among older adults in Central and Eastern Europe

open access: yesAnnals of Medicine
Objective The aim of this study was to examine the prevalence of potentially inappropriate medication (PIM) use and its associated risk factors in community-dwelling older adults from five Central and Eastern European (CEE) countries.Materials and ...
Jovana Brkic   +11 more
doaj   +1 more source

Prevalence of potentially inappropriate medication use in older population: comparison of the Finnish Meds75+ database with eight published criteria

open access: yesBMC Geriatrics, 2023
Background There are several national and international criteria available for identifying potentially inappropriate medications (PIMs) for older people. The prevalence of PIM use may vary depending on the criteria used.
Jasmin Paulamäki   +3 more
doaj   +1 more source

Assessment of Potentially Inappropriate Medications Using the EU (7)-PIM List, in a Sample of Portuguese Older Adults’ Residents in Nursing Homes

open access: yesRisk Management and Healthcare Policy, 2022
Prescription of potentially inappropriate medication (PIM) in older adults is associated with poor clinical outcomes. The EU (7)-PIM list was created for the European market to improve pharmacotherapy in older adults.This work aims to characterize the medication profile and assess the presence of PIM, using the EU (7)-PIM list in older adults ...
Ana Isabel Plácido   +6 more
openaire   +5 more sources

Assessment tool for potentially inappropriate medication use in the elderly: a scoping review protocol

open access: yesRevista de Ciências Farmacêuticas Básica e Aplicada, 2020
Potentially Inappropriate Medication for the elderly (PIM) are drugs in which the safety risks may exceed the benefits, especially when there are safer alternatives.
Geovana Schiavo   +3 more
doaj  

Are Lists of Potentially Inappropriate Medications Associated with Hospital Readmissions? A Systematic Review

open access: yesDrugs & Aging
Suboptimal prescribing, including the prescription of potentially inappropriate medications (PIM), is frequent in patients aged 65 years and older. PIMs are associated with adverse drug events, which may lead to hospital admissions and readmissions for the most serious cases.
Schwab, Camille   +4 more
openaire   +3 more sources

Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan

open access: yesPharmacoepidemiology and Drug Safety, 2012
ABSTRACTBackgroundExplicit criteria for potentially inappropriate medications (PIMs) developed from other regions were often difficult to apply to a specific territory without significant modifications.PurposeTo describe a process of developing a country‐specific explicit PIM criteria from quality review of several published PIM criteria, followed by ...
Chirn-Bin, Chang   +7 more
openaire   +2 more sources

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Impact of Age on the Diagnostic Yield of Routine EEG in People With Childhood or Juvenile Absence Epilepsy: A Cross‐Sectional Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background We aimed to identify the proportion of individuals with a confirmed diagnosis of childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE) who show a negative routine EEG (rEEG), and to determine the main factors associated with this finding.
Francesco Fortunato   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy